arrow_back Civic Audit
Share share

Emergency Funds to Address Infant Formula Shortage

This act allocates $28 million for urgent actions to resolve the shortage of infant formula and certain medical foods in the U.S. The funds are also intended to prevent future shortages and protect the market from fraudulent products. Citizens can expect improved availability of these crucial products.
Key points
Allocates $28 million to increase the availability of infant formula and medical foods.
Measures to prevent future shortages and protect against fraudulent products.
FDA will regularly report on the use of these funds.
article Official text account_balance Process page notifications_active Track this Bill
55%
VOTING RESULTS
2022-05-19
For 231
Against 192
Abstain 0
Full voting results open_in_new
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 117_HR_7790
Sponsor: Rep. DeLauro, Rosa L. [D-CT-3]
Process start date: 2022-05-17
Voting date: 2022-05-19
Meeting no: 2
Voting no: 220
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Infant Formula Supplemental Appropriations Act, 2022

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_7790.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-05-17.

What are the main provisions?

Key points include:

  • Allocates $28 million to increase the availability of infant formula and medical foods.
  • Measures to prevent future shortages and protect against fraudulent products.
  • FDA will regularly report on the use of these funds.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Where is the official voting record?

The official roll call vote is recorded at: voting record

Who is the primary sponsor?

The primary sponsor is Rep. DeLauro, Rosa L. [D-CT-3].

What is the latest detailed status?

The latest detailed status is: Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 374.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

What is the impact of this bill?

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health Family